Bernadette Mannaerts

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

George F. Borm, Bernadette Mannaerts · Human Reproduction · 2000 · 376 citations · Full text

Medicine, Endocrinology, Gynecology +16

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

Anders Nyboe Andersen, Scott M. Nelson, Bart C.J.M. Fauser et al. · Fertility and Sterility · 2016 · 286 citations · Full text

Veterinary Medicine, Gynecology, Obstetrics +15

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

Paul Devroey, R. Boostanfar, N.P. Koper et al. · Human Reproduction · 2009 · 215 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +15

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

Henk J. Out, Bernadette Mannaerts, Stefan Driessen et al. · Human Reproduction · 1995 · 214 citations

Medicine, Endocrinology, Gynecology +17

Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

Joseph Itskovitz‐Eldor, Shahar Kol, Bernadette Mannaerts · Human Reproduction · 2000 · 201 citations

Medicine, Endocrinology, Gynecology +15